Navigation Links
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
Date:2/1/2012

search Center; Director, Colorectal Cancer Translational Research Program; and Chair, Ad Interim, Department of Cancer Biology. Dr. Ellis is vice-chair of the NCI Colon Cancer Task Force and serves on 8 editorial boards, including Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research. Dr. Ellis has served in leadership roles in major cancer societies including ASCO, American Association for Cancer Research, and the Society for Surgical Oncology.

Dr. Matthew Kulke is a world expert in neuroendocrine (NET) tumors. He is Associate Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute, where he leads the Carcinoid and Neuroendocrine Tumor Program. He has a leadership role in the Cancer and Leukemia Group B (CALGB) Gastrointestinal Cancer Committee, chairs the NCI NET Task Force and NCCN NET guidelines committees, and serves on the executive committee of the North American Neuroendocrine Tumor Society. Dr. Kulke has chaired multiple global pivotal studies exploring new therapies for NET.

About NKP-1339
NKP-1339 is a first-in-class small molecule anti-cancer compound that down-regulates GRP78, a known tumor survival and anti-apoptosis factor. In preclinical studies, NKP-1339 has demonstrated activity against multiple tumor types. In the Phase I trial, antitumor activity was seen against multiple cancers, including NET.

About NKP-2235
NKP-2235 is a first-in-class orally available small molecule that targets the endoplasmic reticulum with a unique pattern of cytotoxicity. NKP-2235 IND has been cleared and a Phase I trial will be initiated shortly.

NKP-1339 and NKP-2235 were discovered by Professor Bernhard Keppler, University of Vienna, Austria.

About Niiki Pharma Inc.
Niiki Pharma (www.niikipharma.com) is a development focused oncology company specializing in first-in-class
'/>"/>

SOURCE Niiki Pharma Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results
2. Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent NKP-1339
3. Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents
4. Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 AARP Foundation today announced it ... adults suffering from the severe cold weather that has gripped ... to helping those in need; so to support these emergency ... up to $250,000, which could mean up to $500,000 in ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide ... from the Journal of Drugs in Dermatology ... Conference (ODAC). The event is January 17-20, 2014, at the Omni ... . The ODAC is a distinguished ...
(Date:1/15/2014)... WOONSOCKET, R.I. , Jan. 15, 2014 MultiCell ... has filed a U.S. provisional patent application concerning composition ... formulations to achieve targeted tumor cell death.  ... very small noncoding double stranded RNA molecules (VSRNAs) which ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Pharmaceuticals, Inc. (NYSE Amex: INO ), a ... against cancers and infectious diseases, announced today that the ... technology at the 14th Annual Meeting of the American ... May 18-21 in Seattle, Washington at the Washington State ...
... Shenghuo Pharmaceutical Holdings, Inc. (NYSE Alternext US: KUN) ("China Shenghuo" ... first quarter ended March 31, 2011. F ... Highlights Total revenue increased to $9.4 million ... Net cash provided by operating activities was approximately $2.6 ...
Cached Medicine Technology:Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 2Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 3Inovio Pharmaceuticals to Present at American Society of Gene & Cell Therapy Annual Meeting May 18 - 21, 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 2China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 3China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 4China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 5China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 6China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 7China Shenghuo Pharmaceutical Reports Financial Results for the First Quarter of 2011 8
(Date:7/10/2014)... electronic health record becomes widespread across the United States, ... Care Act, the quantity of clinical data that will ... dramatically increase. Additionally, experts in healthcare have become ... of data for the purpose of gleaning insights that ... care a process that is known as big ...
(Date:7/10/2014)... Fischer HealthDay Reporter THURSDAY, ... ease the hot flashes that often accompany menopause, new research ... 50 percent of menopausal women, said Dr. Taraneh Shirazian, an ... the Icahn School of Medicine at Mount Sinai Hospital in ... than 10 hot flashes a day, and she added that ...
(Date:7/10/2014)... (Boston) Emergency Medical Service (EMS) responders felt better ... receiving focused tactical training according to a new study ... This is the first study to specifically examine the ... scene where a shooter has not yet been neutralized ... , Incidents such as the Columbine High School shooting, ...
(Date:7/10/2014)... the "Mississippi baby" an infant seemingly cured of HIV ... remission of HIV infection in The New England Journal ... after more than two years of not taking antiretroviral therapy ... and researchers involved in the case. , "Certainly, ... child, the medical staff involved in the child,s care, and ...
(Date:7/10/2014)... University of Huddersfield could help to improve the quality ... such as butter, mayonnaise, yoghurt and fruit drinks ... profile for her work. , Katerina gained her MSc ... and now she has embarked on research for a ... she is investigating the potential of carbohydrates extracted from ...
Breaking Medicine News(10 mins):Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:Active shooter training increases comfort level of emergency responders 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:World interest in research work on the benefits of the Okra plant 2
... short of water supply pushing the civic authorities to ration ... population needs eight million gallons of water daily, it has ... Corporation. ,Civic officials said that starting Thursday, water ... ,According to one estimate, 1.5 million gallons of ...
... Smt. Panabaka Lakshmi Inaugurated the Orientation and Capacity Building ... on “Strategies for Conservation and Cultivation of Medicinal Plants” ... that our strategies and action plans should focus not ... in the forest areas but promote cultivation of medicinal ...
... the University of Nottingham are exploring the medical condition which ... ,David Humes of the Division of Gastroenterology, in ... to understand pain, has begun to delve into pain caused ... ,Dr David Humes said: "Our aim is to discover ...
... The World Health Organization (WHO) Thursday expressed alarm over ... motorcycles in Asia//, warning that the situation has become ... that young motorcyclists make up a significant percentage of ... countries, such as Cambodia and Malaysia. ,"Factors ...
... is cigarette smoking there is probably misuse of alcohol ... Medicine researchers in the Archives// of Internal Medicine. ... as a clinical indicator for alcohol misuse, which presents ... McKee, assistant professor of psychiatry. ,She said ...
... deficiency is common and cancer risk is higher among those ... , ,Epidemiological and basic science research, as well as ... preventive and therapeutic cancer agent, suggest that vitamin D deficiency ... types of cancer and increase the likelihood of numerous complications ...
Cached Medicine News:Health News:Exports Of Herbal & Dietary Products Has Huge Potential 2Health News:Smoking Indicator of Alcohol Misuse 2Health News:Deficiency in Vitamin D Increases the Risk of Cancer 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: